Apremilast improves disease severity and patient-reported outcomes among adults with psoriasis, regardless of genital involvement.

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic dermatitis and psoriasis in a skin biopsy, according to a press release.

For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an effective treatment.

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to ...

Discover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.

Opens in a new tab or window A study published in JAAD assessed the rates of suicidal and self-injurious behaviors (SSIBs) among patients with psoriasis or psoriatic arthritis treated with biologics.

Protagonist Therapeutics, Inc.'s VERIFY and ANTHEM-UC studies show breakthroughs in polycythemia vera and ulcerative colitis. Click fo rmy PTGX update.

the company did use the conference to reinforce the findings from a previous phase 3 plaque psoriasis win for icotrokinra in the Iconic-Lead study. J&J reported back in November that Iconic-Lead ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...

Blue­bird bio went from a high-fly­ing $10 bil­lion com­pa­ny in 2018 dur­ing the hey­day of gene ther­a­py to be­ing sold for a measly $29 mil­lion … ...

SFA-002 met its exploratory endpoint of efficacy. Patients administered SFA-002 demonstrated statistically significant Psoriasis Area and Severity Index (PASI) percentage change and Investigator ...